An estimated 20–25% of the population is affected by chronic, non-communicable
inflammatory skin diseases. Chronic skin inflammation has many causes. Among the most …

The majority of patients with systemic lupus erythematosus (SLE) have cutaneous
manifestations at some point in their disease course. The skin findings in SLE are classified …

Abstract This year, the American College of Rheumatology (ACR) 1982 classification criteria
for systemic lupus erythematosus (SLE) celebrate their 40th anniversary. From this start, the …

Introduction Between 5 and 25% of patients with cutaneous lupus erythematosus (CLE) can
progress to systemic lupus erythematosus (SLE) during the course of the disease. There is …

Abstract Systemic Lupus Erythematosus (SLE) is an autoimmune multisystem disease with a
variable clinical phenotype and no single clinical, laboratory or pathological feature that can …

ABSTRACT Introduction The European League Against Rheumatism/American College of
Rheumatology (EULAR/ACR) classification criteria for systemic lupus erythematosus (SLE) …

Системная красная волчанка (СКВ)-аутоиммунное ревматическое заболевание
неизвестной этиологии, характеризующееся гиперпродукцией органонеспецифических …

Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease of unknown
etiology, characterized by overproduction of organ-nonspecific autoantibodies to various …

The antinuclear antibody (ANA) test has high sensitivity in diagnosing and classifying
systemic lupus erythematosus (SLE). Objectives To describe the immunological pattern of …

Objective The Systemic Lupus International Collaborating Clinics (SLICC) 2012 systemic
lupus erythematosus (SLE) classification criteria and the revised American College of …